Capnia Inc., a leading provider and developer of innovative healthcare products to be used for the screening, detection, and treatment of medical conditions has joined forces with Essentialis Inc., a clinical-stage pharmaceutical company focused on the development of breakthrough medicines. The companies entered into a definitive merger agreement on December 27, 2016 to create a rare disease therapeutics company. Read More